Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Spoladore

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Indian Heart Journal|June 27, 2017
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertensionRoberto Spoladore, Francesco Maranta, Gabriele Fragasso
Advances in Experimental Medicine and Biology|November 20, 2016
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial HypertensionFrancesco Maranta, Roberto Spoladore, Gabriele Fragasso
European Journal of Internal Medicine|May 27, 2019
Multimodality imaging of aortopulmonary paragangliomaFrancesco Melillo, Roberto Spoladore, Alberto Margonato
Case Reports in Medicine|July 9, 2011
Left ventricular "diverticulum" in a patient affected by galactosialidosisAlessandro Durante, Mariaemilia Traini, Roberto Spoladore
European Heart Journal. Case Reports|October 15, 2021
Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatmentGiorgio Fiore, Francesca Sanvito, Gabriele Fragasso, et al.
Current Clinical Pharmacology|August 12, 2008
Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolaseGabriele Fragasso, Roberto Spoladore, Amarild Cuko, et al.
Trends in Cardiovascular Medicine|August 21, 2018
Metabolic effects of cardiovascular drugsGabriele Fragasso, Alberto Margonato, Roberto Spoladore, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
How much does eliminating one or two cardiovascular risk factors matter?: Evidence from the Global Cardiovascular Risk ConsortiumRoberto Spoladore, Stefano Pedroli, Andrea Tacchetto, et al.
Heart Failure Reviews|November 30, 2025
Heart failure with preserved ejection fraction, from pathophysiology to technology tools aim improve patients' managementAndrea Pozzi, Roberto Spoladore, Annamaria Iorio, et al.
JACC. Case Reports|July 28, 2021
A Unique Case of Mitral Valve Double Papillary Muscle RuptureLuigi Pannone, Giulio Falasconi, Alberto Margonato, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Indian Heart Journal|June 27, 2017
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertensionRoberto Spoladore, Francesco Maranta, Gabriele Fragasso
Advances in Experimental Medicine and Biology|November 20, 2016
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial HypertensionFrancesco Maranta, Roberto Spoladore, Gabriele Fragasso
European Journal of Internal Medicine|May 27, 2019
Multimodality imaging of aortopulmonary paragangliomaFrancesco Melillo, Roberto Spoladore, Alberto Margonato
Case Reports in Medicine|July 9, 2011
Left ventricular "diverticulum" in a patient affected by galactosialidosisAlessandro Durante, Mariaemilia Traini, Roberto Spoladore
European Heart Journal. Case Reports|October 15, 2021
Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatmentGiorgio Fiore, Francesca Sanvito, Gabriele Fragasso, et al.
Current Clinical Pharmacology|August 12, 2008
Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolaseGabriele Fragasso, Roberto Spoladore, Amarild Cuko, et al.
Trends in Cardiovascular Medicine|August 21, 2018
Metabolic effects of cardiovascular drugsGabriele Fragasso, Alberto Margonato, Roberto Spoladore, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
How much does eliminating one or two cardiovascular risk factors matter?: Evidence from the Global Cardiovascular Risk ConsortiumRoberto Spoladore, Stefano Pedroli, Andrea Tacchetto, et al.
Heart Failure Reviews|November 30, 2025
Heart failure with preserved ejection fraction, from pathophysiology to technology tools aim improve patients' managementAndrea Pozzi, Roberto Spoladore, Annamaria Iorio, et al.
JACC. Case Reports|July 28, 2021
A Unique Case of Mitral Valve Double Papillary Muscle RuptureLuigi Pannone, Giulio Falasconi, Alberto Margonato, et al.
Pageof 7